Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature
Open Access
- 6 August 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 18 (12), 3252-3260
- https://doi.org/10.1245/s10434-011-1951-5
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989–2006Annals Of Oncology, 2010
- Ten years experience of managing the primary tumours in patients with stage IV colorectal cancersInternational Journal of Surgery, 2010
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved ChemotherapyJournal of Clinical Oncology, 2009
- A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned?European Journal Of Cancer, 2009
- Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial TreatmentJournal of Clinical Oncology, 2009
- Outcomes of resection and non-resection strategies in management of patients with advanced colorectal cancerWorld Journal of Surgical Oncology, 2009
- Primary tumour resection and survival in the palliative management of metastatic colorectal cancerEuropean Journal of Surgical Oncology, 2009
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal CancerNew England Journal of Medicine, 2009
- Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741Journal of Clinical Oncology, 2008
- KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With CetuximabJournal of Clinical Oncology, 2008